STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
STERIS reported full year fiscal 2026 revenue of $5.9 billion, up 9% year-over-year, with constant currency organic revenue growth of 7%. As reported, diluted EPS from continuing operations increased to $7.93, and adjusted EPS per diluted share rose to $10.17, up from $9.22 in fiscal 2025. The company expects fiscal 2027 revenue to grow 7-8% YoY, with constant currency organic revenue growth of 6-7% and adjusted EPS in the range of $11.10 to $11.30.
Key figures
- Eps
- 7.93
- Eps Beat
- 0
- Revenue
- 5900000000
- Guidance
- Fiscal 2027 revenue 7-8% YoY; constant currency organic revenue 6-7% YoY; adjusted EPS $11.10-$11.30, up 9-11% from fiscal 2026
- Revenue Yoy
- 9%
- Net income
- 782300000
- Adjusted eps
- 10.17
- Free cash flow
- 982900000
- Adjusted net income
- 1000000000
- Capital expenditures
- 375000000
- Strategic investment
- 60000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.